The rate of amenorrhea at 12-months post-ablation was significantly higher in women treated by Novasure ( 25/33 ; 75.8 % ) as compared to those treated by MEA ( 8/33 ; 24.2 % ) ( rate difference : +51.5 % , 95 % CI : +27.8 to +67.7 ) .